↓ Skip to main content

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

Overview of attention for article published in PLOS ONE, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs
1 blog
patent
5 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
354 Dimensions

Readers on

mendeley
251 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Published in
PLOS ONE, September 2009
DOI 10.1371/journal.pone.0007258
Pubmed ID
Authors

Patrice Dubreuil, Sébastien Letard, Marco Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S. Leventhal, Colin D. Mansfield, Alain Moussy, Olivier Hermine

Abstract

The stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine kinase inhibitor that targets KIT.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 2 <1%
Brazil 2 <1%
Germany 1 <1%
Switzerland 1 <1%
United Kingdom 1 <1%
Mexico 1 <1%
Belgium 1 <1%
Unknown 242 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 50 20%
Student > Ph. D. Student 35 14%
Other 27 11%
Student > Master 25 10%
Student > Bachelor 23 9%
Other 40 16%
Unknown 51 20%
Readers by discipline Count As %
Medicine and Dentistry 47 19%
Agricultural and Biological Sciences 36 14%
Biochemistry, Genetics and Molecular Biology 28 11%
Pharmacology, Toxicology and Pharmaceutical Science 21 8%
Chemistry 20 8%
Other 43 17%
Unknown 56 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2022.
All research outputs
#2,357,950
of 26,017,215 outputs
Outputs from PLOS ONE
#28,681
of 225,486 outputs
Outputs of similar age
#7,684
of 111,037 outputs
Outputs of similar age from PLOS ONE
#75
of 542 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 225,486 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,037 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 542 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.